News

Chromogenic Factor VIII Assay Cleared for Sale in Canada, EU, Australia, and New Zealand

January 20, 2020

Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the availability of its new CRYOcheck Chromogenic Factor VIII assay in Canada, the European Union, Australia, and New Zealand following market authorization by Health Canada and respective in-country regulatory authorities.

CRYOcheck Chromogenic Factor VIII is intended for use by clinical labs for the determination of FVIII activity in human plasma and as an aid in the management of hemophilia A. Studies¹ have shown the chromogenic method to be less prone to interference from lipids or traces of heparin than clot-based FVIII activity tests, offering unsurpassed assurance in results, especially in cases of severe hemophilia A.

Happy New Year

January 02, 2020

2020 is upon us and we're gearing up for an eventful year. Check out our updated list of conferences. We hope to see you there!

Holiday Hours

November 22, 2019

Please note that Precision BioLogic will be closed December 25 to January 1. We will reopen the morning of January 2 and our regular shipping schedule will resume January 6.

To avoid potential shipping delays during the holidays, please order by December 13.

Effects of Common Interferents in Hexagonal Phase Phospholipid Neutralization Testing

September 18, 2019

Today, Precision BioLogic unveiled data from a recent study at the 16th International Congress on Antiphospholipid Antibodies (ICAPA 2019) in Manchester, UK.

See you in Manchester?

September 10, 2019

Heading to Manchester for ICAPA 2019? If so, we'd love to see you. Drop by and visit us at Booth 10. And, be sure to attend our poster presentation, Wednesday, September 18, 12:30–1:30 pm:

Fritsma Factor Quick Questions

July 18, 2019

Did you know? Each month, the Fritsma Factor features a Quick Question inviting visitors to weigh in on a hemostasis-related topic. At the end of the month, George Fritsma summarizes the results.

Check it out and have your say!

ISTH 2019: The Countdown Is On

June 21, 2019

We're counting the days until ISTH 2019 and hope to see you there. Visit us and our colleagues from Affinity Biologicals at Booth 735 to see what we're up to!

Webinar Recording Now Available

May 21, 2019

A recording of our May 15 webinar, Update on FVIII Inhibitor Testing and Introduction to the CRYOcheck™ Factor VIII Inhibitor Kit with guest speaker Connie H. Miller, PhD, is now available on Our Webinars page.

ISLH 2019

May 03, 2019

Heading to Vancouver for ISLH May 9-11? If so, we’d love to see you. Drop by and visit Precision BioLogic and Affinity Biologicals at booth 503.

Lab Week 2019

April 21, 2019

Lab Week. In Canada, it's National Medical Laboratory Week. In the U.S., it's Medical Laboratory Professionals Week. No matter what you call it, it's a time to recognize clinical laboratory professionals and all that they bring to their vital role in health care.

Lab Week runs April 21–27 this year. In support, we're hosting a FREE WEBINAR next month:

World Hemophilia Day 2019: Reaching Out

April 12, 2019

April 17 is World Hemophilia Day and Precision BioLogic is proud to support this important World Federation of Hemophilia initiative. This year, the focus is on outreach and identification as the “first step to care." Visit worldhemophiliaday.org to share your stories of diagnosis along with efforts to increase outreach and identification.

Factor VIII Inhibitor Kit Cleared for Sale in U.S.

March 13, 2019

Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce FDA 510(k) clearance and the launch of its CRYOcheck™ Factor VIII Inhibitor Kit in the U.S. This clearance follows approvals received from regulatory authorities in Canada, the European Union, Australia, and New Zealand, where the kit launched in February of this year.

New Product to Improve Inhibitor Testing for People with Hemophilia A

February 11, 2019

Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the availability of its new CRYOcheck™ Factor VIII Inhibitor Kit in Canada, the European Union, Australia, and New Zealand following market authorization by Health Canada and respective in-country regulatory authorities last month.

Happy New Year

January 02, 2019

2019 is upon us and we're gearing up for an eventful year. Check out our updated list of conferences. We hope to see you there!

Standardized Kit for a Chromogenic MNBA: Repeatability, Reproducibility, and Analytical Sensitivity

December 03, 2018

On December 1, Precision BioLogic unveiled data from a study using a new kit for a Modified Nijmegen-Bethesda Assay (MNBA) at the 60th ASH Annual Meeting in San Diego, CA.

News

Pages